[<sup>11</sup>C] K-2, the first Positron Emission Tomography Tracer for AMPA receptors available for living human brain, Characterize patients with schizophrenia.

Mai Hatano, Waki Nakajima, Tomoyuki Miyazaki, Tsuyoshi Eiro, Kotaro Nakano, Hiroyuki Uchida, Takuya Takahashi

[4P-429] [¹¹C] K-2, the first Positron Emission Tomography Tracer for AMPA receptors available for living human brain, Characterize patients with schizophrenia.

〇Mai Hatano¹, Waki Nakajima¹, Tomoyuki Miyazaki¹, Tsuyoshi Eiro¹, Kotaro Nakano¹, Hiroyuki Uchida², Takuya Takahashi¹ (1.Department of Physiology Grad Sch Med, Univ of Yokohama City, Kanagawa, Japan, 2.Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

Keywords:AMPA, Schizophrenia, PET

Abstract password authentication.
A password is required to view the full text of the abstract. Please refer to the member site for the password.

https://membership.jnss.org/C00/login

Presentation information

[4P] Schizophrenia

[4P-429] [¹¹C] K-2, the first Positron Emission Tomography Tracer for AMPA receptors available for living human brain, Characterize patients with schizophrenia.

Password

Presentation information

[4P] Schizophrenia

[4P-429] [11C] K-2, the first Positron Emission Tomography Tracer for AMPA receptors available for living human brain, Characterize patients with schizophrenia.

Password

[4P-429] [¹¹C] K-2, the first Positron Emission Tomography Tracer for AMPA receptors available for living human brain, Characterize patients with schizophrenia.